European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma
European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma have?
European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma has 177 citations in the OpenAlex counts ScholarIQ stores.
When was European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma published?
European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma has 2023 year in the ScholarIQ index.
What is the open-access status of European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma?
European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma has hybrid oa status in the ScholarIQ index.
What is the DOI of European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma?
The DOI for European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma is on the source record.
What is the PMID of European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma?
The PMID for European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma is on the source record.
What is the OpenAlex record for European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma?
The OpenAlex for European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma is on the source record.